Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Chondrial_Therapeutics
|
| gptkbp:acquisitionYear |
2020
|
| gptkbp:CEO |
gptkb:Thomas_Hughes
|
| gptkbp:focusesOn |
obesity
rare diseases metabolic diseases |
| gptkbp:foundedIn |
2005
|
| gptkbp:headquartersLocation |
gptkb:Boston,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Zafgen
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
gptkb:beloranib
|
| gptkbp:status |
acquired
|
| gptkbp:tradedOn |
gptkb:NASDAQ:ZFGN
|
| gptkbp:website |
www.zafgen.com
|
| gptkbp:bfsParent |
gptkb:Jean-François_Formela
gptkb:Ropes_&_Gray_LLP |
| gptkbp:bfsLayer |
7
|